activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2948895	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cccc2c1-c1[nH]nc(NCc3c(C)cccc3Cl)c1C2		CHEMBL574630	<	IC50	nM	10000.0	CHEMBL6029	Homo sapiens	pIC50		5.0
	2948895	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cccc2c1-c1[nH]nc(NCc3c(C)cccc3Cl)c1C2		CHEMBL574630	<	IC50	nM	10000.0	CHEMBL6029	Homo sapiens	pIC50		5.0
	2948896	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3c(Cl)cccc3Cl)c1CC2		CHEMBL566755	<	IC50	nM	10000.0	CHEMBL6029	Homo sapiens	pIC50		5.0
	2948897	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3c(Cl)cccc3Cl)c1CCC2		CHEMBL566756	<	IC50	nM	10000.0	CHEMBL6029	Homo sapiens	pIC50		5.0
	2948898	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1ccccc1CNc1n[nH]c2c1Cc1cc(OC)c(OC)cc1-2		CHEMBL577153	=	IC50	nM	3162.28	CHEMBL6029	Homo sapiens	pIC50		5.5
	2948899	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3ccc(Cl)cc3)c1C2		CHEMBL574010	=	IC50	nM	2511.89	CHEMBL6029	Homo sapiens	pIC50		5.6
	2948900	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3c(Cl)cccc3Cl)c1C2		CHEMBL578663	=	IC50	nM	2511.89	CHEMBL6029	Homo sapiens	pIC50		5.6
	2948901	CHEMBL1058424	Inhibition of human HRI kinase	B	Cc1cccc(Cl)c1CNc1n[nH]c2c1Cc1ccccc1-2		CHEMBL583189	=	IC50	nM	1584.89	CHEMBL6029	Homo sapiens	pIC50		5.8
	2948902	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3ccc(Cl)cc3Cl)c1C2		CHEMBL575915	=	IC50	nM	1258.93	CHEMBL6029	Homo sapiens	pIC50		5.9
	2948903	CHEMBL1058424	Inhibition of human HRI kinase	B	CSc1ccc2c(c1)-c1[nH]nc(NCc3c(C)cccc3Cl)c1C2		CHEMBL575078	=	IC50	nM	1000.0	CHEMBL6029	Homo sapiens	pIC50		6.0
	2948904	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3cccc(Cl)c3)c1C2		CHEMBL574006	=	IC50	nM	1000.0	CHEMBL6029	Homo sapiens	pIC50		6.0
	2948905	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cccc2c1Cc1c(NCc3c(C)cccc3Cl)n[nH]c1-2		CHEMBL575914	=	IC50	nM	794.33	CHEMBL6029	Homo sapiens	pIC50		6.1
	2948906	CHEMBL1058424	Inhibition of human HRI kinase	B	Cc1cccc(Cl)c1CNc1n[nH]c2c1Cc1ccc(Br)cc1-2		CHEMBL573280	=	IC50	nM	794.33	CHEMBL6029	Homo sapiens	pIC50		6.1
	2948907	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3ccccc3)c1C2		CHEMBL574208	=	IC50	nM	630.96	CHEMBL6029	Homo sapiens	pIC50		6.2
	2948908	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1ccc2c(c1)Cc1c(NCc3c(C)cccc3Cl)n[nH]c1-2		CHEMBL575913	=	IC50	nM	501.19	CHEMBL6029	Homo sapiens	pIC50		6.3
	2948909	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2sc3c(NCc4c(C)cccc4Cl)n[nH]c3c2cc1OC		CHEMBL582642	=	IC50	nM	501.19	CHEMBL6029	Homo sapiens	pIC50		6.3
	2948910	CHEMBL1058424	Inhibition of human HRI kinase	B	CCc1ccc2c(c1)-c1[nH]nc(NCc3c(C)cccc3Cl)c1C2		CHEMBL576948	=	IC50	nM	316.23	CHEMBL6029	Homo sapiens	pIC50		6.5
	2948911	CHEMBL1058424	Inhibition of human HRI kinase	B	Cc1cccc(Cl)c1CNc1n[nH]c2c1Cc1cc3c(cc1-2)OCO3		CHEMBL573770	=	IC50	nM	251.19	CHEMBL6029	Homo sapiens	pIC50		6.6
	2948912	CHEMBL1058424	Inhibition of human HRI kinase	B	Cc1cccc(Cl)c1CNc1n[nH]c2c1Cc1ccc(N(C)C)cc1-2		CHEMBL574009	=	IC50	nM	251.19	CHEMBL6029	Homo sapiens	pIC50		6.6
	2948913	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3ccccc3Cl)c1C2		CHEMBL573763	=	IC50	nM	199.53	CHEMBL6029	Homo sapiens	pIC50		6.7
	2948914	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc(OC)c2c(c1)-c1[nH]nc(NCc3c(C)cccc3Cl)c1C2		CHEMBL574209	=	IC50	nM	125.89	CHEMBL6029	Homo sapiens	pIC50		6.9
	2948915	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)S(=O)(=O)c1c(NCc3c(Cl)cccc3Cl)n[nH]c1-2		CHEMBL583635	=	IC50	nM	79.43	CHEMBL6029	Homo sapiens	pIC50		7.1
	2948916	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3ccccc3C)c1C2		CHEMBL574443	=	IC50	nM	63.1	CHEMBL6029	Homo sapiens	pIC50		7.2
	2948917	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2oc3c(NCc4c(Cl)cccc4Cl)n[nH]c3c2cc1OC		CHEMBL565272	=	IC50	nM	63.1	CHEMBL6029	Homo sapiens	pIC50		7.2
	2948918	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1ccc2c(c1)-c1[nH]nc(NCc3c(C)cccc3Cl)c1C2		CHEMBL578836	=	IC50	nM	50.12	CHEMBL6029	Homo sapiens	pIC50		7.3
	2948919	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OCC(O)CO)Cc1c(NCc3c(Cl)cccc3Cl)n[nH]c1-2		CHEMBL574005	=	IC50	nM	31.62	CHEMBL6029	Homo sapiens	pIC50		7.5
	2948920	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3c(C)cccc3Cl)c1C2		CHEMBL576168	=	IC50	nM	19.95	CHEMBL6029	Homo sapiens	pIC50		7.7
	2948921	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3c(C)cccc3C)c1C2		CHEMBL578426	=	IC50	nM	7.943	CHEMBL6029	Homo sapiens	pIC50		8.1
	2948922	CHEMBL1058424	Inhibition of human HRI kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(NCc3c(Cl)cccc3Cl)c1C2=O		CHEMBL573760	=	IC50	nM	6.31	CHEMBL6029	Homo sapiens	pIC50		8.2
	3052628	CHEMBL1038414	Residual activity of HRI at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	87.0	CHEMBL6029	Homo sapiens	Residual activity	%	87.0
	3053937	CHEMBL1046829	Residual activity of HRI at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	57.0	CHEMBL6029	Homo sapiens	Residual activity	%	57.0
	3054189	CHEMBL1040657	Residual activity of HRI at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	113.0	CHEMBL6029	Homo sapiens	Residual activity	%	113.0
	3055476	CHEMBL1038414	Residual activity of HRI at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	108.0	CHEMBL6029	Homo sapiens	Residual activity	%	108.0
	3056781	CHEMBL1046829	Residual activity of HRI at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	127.0	CHEMBL6029	Homo sapiens	Residual activity	%	127.0
	3057033	CHEMBL1040657	Residual activity of HRI at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	92.0	CHEMBL6029	Homo sapiens	Residual activity	%	92.0
	3058353	CHEMBL1038414	Residual activity of HRI at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	108.0	CHEMBL6029	Homo sapiens	Residual activity	%	108.0
	3058605	CHEMBL1046829	Residual activity of HRI at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	112.0	CHEMBL6029	Homo sapiens	Residual activity	%	112.0
	3072951	CHEMBL1040657	Residual activity of HRI at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	98.0	CHEMBL6029	Homo sapiens	Residual activity	%	98.0
	3358549	CHEMBL1174394	Inhibition of EIF2AK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	83.0	CHEMBL6029	Homo sapiens	INH	%	83.0
	3358991	CHEMBL1174394	Inhibition of EIF2AK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	72.0	CHEMBL6029	Homo sapiens	INH	%	72.0
	7567480	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	3100.0	CHEMBL6029	Homo sapiens	Kd	nM	3100.0
	7567497	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7567968	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7568436	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7568868	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7569471	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7569943	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7570406	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7570833	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7570987	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7571444	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7571920	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7572383	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7572799	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7572968	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7573425	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7573901	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7574370	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7574946	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7575407	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7575878	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7576309	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7576920	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7577379	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	980.0	CHEMBL6029	Homo sapiens	Kd	nM	980.0
	7577885	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7578290	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1000.0	CHEMBL6029	Homo sapiens	Kd	nM	1000.0
	7578928	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7579302	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7579752	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	870.0	CHEMBL6029	Homo sapiens	Kd	nM	870.0
	7579784	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7580253	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7580656	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7581286	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7581671	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7582145	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7582609	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7583009	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7584032	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7584503	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7584965	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7585369	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7585520	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7585928	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7586374	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7586845	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7587299	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7587481	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7587900	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7588353	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7588824	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7589275	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7589446	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7589870	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7590337	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7590811	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7591419	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7591841	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7592313	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7592797	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7593386	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7593821	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7594293	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7594324	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7594776	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	630.0	CHEMBL6029	Homo sapiens	Kd	nM	630.0
	7595354	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7595798	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7596301	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7596748	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7597326	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1500.0	CHEMBL6029	Homo sapiens	Kd	nM	1500.0
	7597810	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7598280	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	7598722	CHEMBL1908777	Binding constant for EIF2AK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL6029	Homo sapiens	Kd	nM	10000.0
	8004898	CHEMBL1942918	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 2.5 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL530543	=	Ratio		11.0	CHEMBL6029	Homo sapiens	Ratio		11.0
	8004899	CHEMBL1942918	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 2.5 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL534675	=	Ratio		11.0	CHEMBL6029	Homo sapiens	Ratio		11.0
	8004900	CHEMBL1942919	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 5 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccc(Cl)c(Cl)c1		CHEMBL10835	=	Ratio		11.0	CHEMBL6029	Homo sapiens	Ratio		11.0
	8004901	CHEMBL1942919	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 5 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	COc1cc(NC(=O)Nc2ccc(Cl)c(Cl)c2)ccc1C		CHEMBL1940088	<	Ratio		2.0	CHEMBL6029	Homo sapiens	Ratio		2.0
	8004902	CHEMBL1942919	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 5 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	COc1cc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)ccc1C		CHEMBL1940089	=	Ratio		8.0	CHEMBL6029	Homo sapiens	Ratio		8.0
	8004903	CHEMBL1942919	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 5 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	COc1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)ccc1C		CHEMBL1940090	=	Ratio		9.0	CHEMBL6029	Homo sapiens	Ratio		9.0
	8004967	CHEMBL1943304	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 10 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	Cc1ccc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1O		CHEMBL1940086	=	Ratio		11.0	CHEMBL6029	Homo sapiens	Ratio		11.0
	8004968	CHEMBL1943304	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 10 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	Cc1ccc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1OCCN(C)C		CHEMBL1940093	=	Ratio		9.0	CHEMBL6029	Homo sapiens	Ratio		9.0
	8004969	CHEMBL1943304	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 10 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	Cc1ccc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1OCCN1CCOCC1		CHEMBL1940096	=	Ratio		9.0	CHEMBL6029	Homo sapiens	Ratio		9.0
	8004970	CHEMBL1943304	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 10 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	Cc1ccc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1OCCN1CCNCC1.Cl.Cl		CHEMBL3217205	=	Ratio		9.0	CHEMBL6029	Homo sapiens	Ratio		9.0
	8004971	CHEMBL1942916	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 20 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	Cc1ccc(NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1O		CHEMBL1940085	=	Ratio		11.0	CHEMBL6029	Homo sapiens	Ratio		11.0
Not Active	8004972	CHEMBL1943305	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 2.5 to 20 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	COc1cc(NC(=O)Nc2ccc(Cl)c(Cl)c2)ccc1C		CHEMBL1940088		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004973	CHEMBL1943305	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 2.5 to 20 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	Cc1ccc(NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1OCCN(C)C		CHEMBL1940091		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004974	CHEMBL1943305	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 2.5 to 20 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	Cc1ccc(NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1OCCN1CCOCC1		CHEMBL1940094		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004975	CHEMBL1943305	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 2.5 to 20 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	Cc1ccc(NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1OCCN1CCNCC1.Cl.Cl.Cl.Cl		CHEMBL3217204		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004984	CHEMBL1943308	Activation of EIF2alpha kinase in human CRL2351 cells assessed as phosphorylation of eIF2alpha at 5 uM after 5 hrs by Western blot analysis	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL534675		Activity			CHEMBL6029	Homo sapiens	Activity		
Not Active	8004985	CHEMBL1943308	Activation of EIF2alpha kinase in human CRL2351 cells assessed as phosphorylation of eIF2alpha at 5 uM after 5 hrs by Western blot analysis	B	COc1cc(NC(=O)Nc2ccc(Cl)c(Cl)c2)ccc1C		CHEMBL1940088		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004986	CHEMBL1943308	Activation of EIF2alpha kinase in human CRL2351 cells assessed as phosphorylation of eIF2alpha at 5 uM after 5 hrs by Western blot analysis	B	COc1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)ccc1C		CHEMBL1940090		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004987	CHEMBL1943308	Activation of EIF2alpha kinase in human CRL2351 cells assessed as phosphorylation of eIF2alpha at 5 uM after 5 hrs by Western blot analysis	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1ncccc1O		CHEMBL1940101		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004988	CHEMBL1943303	Activation of EIF2alpha kinase in human CRL2351 cells assessed as CHOP protein expression at 5 uM after 5 hrs by Western blot analysis	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL534675		Activity			CHEMBL6029	Homo sapiens	Activity		
Not Active	8004989	CHEMBL1943303	Activation of EIF2alpha kinase in human CRL2351 cells assessed as CHOP protein expression at 5 uM after 5 hrs by Western blot analysis	B	COc1cc(NC(=O)Nc2ccc(Cl)c(Cl)c2)ccc1C		CHEMBL1940088		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004990	CHEMBL1943303	Activation of EIF2alpha kinase in human CRL2351 cells assessed as CHOP protein expression at 5 uM after 5 hrs by Western blot analysis	B	COc1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)ccc1C		CHEMBL1940090		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004991	CHEMBL1943303	Activation of EIF2alpha kinase in human CRL2351 cells assessed as CHOP protein expression at 5 uM after 5 hrs by Western blot analysis	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1ncccc1O		CHEMBL1940101		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004996	CHEMBL1943681	Activation of EIF2alpha kinase in human CRL2351 cells assessed as CHOP mRNA expression at 5 uM after 5 hrs by PCR analysis	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL534675		Activity			CHEMBL6029	Homo sapiens	Activity		
Not Active	8004997	CHEMBL1943681	Activation of EIF2alpha kinase in human CRL2351 cells assessed as CHOP mRNA expression at 5 uM after 5 hrs by PCR analysis	B	COc1cc(NC(=O)Nc2ccc(Cl)c(Cl)c2)ccc1C		CHEMBL1940088		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004998	CHEMBL1943681	Activation of EIF2alpha kinase in human CRL2351 cells assessed as CHOP mRNA expression at 5 uM after 5 hrs by PCR analysis	B	COc1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)ccc1C		CHEMBL1940090		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8004999	CHEMBL1943681	Activation of EIF2alpha kinase in human CRL2351 cells assessed as CHOP mRNA expression at 5 uM after 5 hrs by PCR analysis	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1ncccc1O		CHEMBL1940101		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	8005000	CHEMBL1943302	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 2.5 to 80 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1ncccc1O		CHEMBL1940101		Activity			CHEMBL6029	Homo sapiens	Activity		
	8005004	CHEMBL1942915	Activation of EIF2alpha kinase in human CRL2351 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly/renilla luciferase ratio at 40 uM after 16 hrs by dual luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ncccc1O		CHEMBL1940100	=	Ratio		12.0	CHEMBL6029	Homo sapiens	Ratio		12.0
	12116252	CHEMBL2172950	Inhibition of HRI assessed as EIF2AK1 phosphorylation	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL2171124	=	IC50	nM	420.0	CHEMBL6029	Homo sapiens	IC50	nM	420.0
	12116253	CHEMBL2172950	Inhibition of HRI assessed as EIF2AK1 phosphorylation	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(Cl)c2)c2c(N)ncnc21		CHEMBL2171122	=	IC50	nM	214.0	CHEMBL6029	Homo sapiens	IC50	nM	214.0
	12116254	CHEMBL2172950	Inhibition of HRI assessed as EIF2AK1 phosphorylation	B	Nc1nccc2scc(-c3ccc4c(c3)CCN4C(=O)Cc3ccccc3)c12		CHEMBL2171133	=	IC50	nM	17020.0	CHEMBL6029	Homo sapiens	IC50	nM	17020.0
	12116255	CHEMBL2172950	Inhibition of HRI assessed as EIF2AK1 phosphorylation	B	Cn1cc(-c2cnc(N)c3c(-c4ccc5c(c4)CCN5C(=O)Cc4ccccc4)csc23)cn1		CHEMBL2171132	=	IC50	nM	1863.0	CHEMBL6029	Homo sapiens	IC50	nM	1863.0
	12116256	CHEMBL2172950	Inhibition of HRI assessed as EIF2AK1 phosphorylation	B	Nc1ncc(-c2cccnc2)c2scc(-c3ccc4c(c3)CCN4C(=O)Cc3ccccc3)c12		CHEMBL2171128	=	IC50	nM	12080.0	CHEMBL6029	Homo sapiens	IC50	nM	12080.0
	12173641	CHEMBL2214017	Inhibition of EIF2AK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL6029	Homo sapiens	Activity	%	100.0
	12183895	CHEMBL2211492	Inhibition of EIF2AK1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL6029	Homo sapiens	pIC50		5.0
	13491934	CHEMBL2443948	Inhibition of HRI (unknown origin) assessed as EIF2AK1 phosphorylation	B	Cc1cc(C)n(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1		CHEMBL2441346	=	IC50	nM	61.0	CHEMBL6029	Homo sapiens	IC50	nM	61.0
	13491935	CHEMBL2443948	Inhibition of HRI (unknown origin) assessed as EIF2AK1 phosphorylation	B	Cn1cc(-c2ccc3c(c2F)CCN3C(=O)Cc2cccc(C(F)(F)F)n2)c2c(N)ncnc21		CHEMBL2441342	=	IC50	nM	37.0	CHEMBL6029	Homo sapiens	IC50	nM	37.0
	13491936	CHEMBL2443948	Inhibition of HRI (unknown origin) assessed as EIF2AK1 phosphorylation	B	Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1		CHEMBL2441340	=	IC50	nM	460.0	CHEMBL6029	Homo sapiens	IC50	nM	460.0
	13866241	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CCC[C@H](Oc2ccc(C(F)(F)F)cc2)C1		CHEMBL3099979	=	Activity	uM	2.7	CHEMBL6029	Homo sapiens	Activity	uM	2.7
	13866242	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CCCC[C@@H]1Oc1ccc(C(F)(F)F)cc1		CHEMBL3099980	=	Activity	uM	1.7	CHEMBL6029	Homo sapiens	Activity	uM	1.7
	13866243	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](OCc2ccc(F)cc2)CC1		CHEMBL3099981	=	Activity	uM	4.4	CHEMBL6029	Homo sapiens	Activity	uM	4.4
	13866244	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2cccc(C(F)(F)F)c2)CC1		CHEMBL3100017	=	Activity	uM	1.1	CHEMBL6029	Homo sapiens	Activity	uM	1.1
	13866245	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccccc2C(F)(F)F)CC1		CHEMBL3100016	=	Activity	uM	1.2	CHEMBL6029	Homo sapiens	Activity	uM	1.2
	13866246	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL3098149	=	Activity	uM	0.3	CHEMBL6029	Homo sapiens	Activity	uM	0.3
	13866247	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(OC(F)(F)F)cc2)CC1		CHEMBL3100015	=	Activity	uM	1.5	CHEMBL6029	Homo sapiens	Activity	uM	1.5
	13866248	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(Cl)cc2)CC1		CHEMBL3100014	=	Activity	uM	1.6	CHEMBL6029	Homo sapiens	Activity	uM	1.6
	13866249	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2cccc(F)c2)CC1		CHEMBL3100013	=	Activity	uM	2.6	CHEMBL6029	Homo sapiens	Activity	uM	2.6
	13866250	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccccc2F)CC1		CHEMBL3100012	=	Activity	uM	3.2	CHEMBL6029	Homo sapiens	Activity	uM	3.2
	13866251	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1ccc(C(=O)O)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100011	=	Activity	uM	21.2	CHEMBL6029	Homo sapiens	Activity	uM	21.2
	13866252	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	COC(=O)c1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)cc1		CHEMBL3100008	=	Activity	uM	12.8	CHEMBL6029	Homo sapiens	Activity	uM	12.8
	13866253	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	COC(=O)c1cccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)c1		CHEMBL3100007	=	Activity	uM	17.1	CHEMBL6029	Homo sapiens	Activity	uM	17.1
	13866254	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	COC(=O)c1ccccc1NC(=O)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3100006	=	Activity	uM	26.2	CHEMBL6029	Homo sapiens	Activity	uM	26.2
	13866255	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	CSc1cccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)c1		CHEMBL3100004	=	Activity	uM	12.2	CHEMBL6029	Homo sapiens	Activity	uM	12.2
	13866256	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1ccc([N+](=O)[O-])cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100002	=	Activity	uM	6.7	CHEMBL6029	Homo sapiens	Activity	uM	6.7
	13866257	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc([N+](=O)[O-])c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100001	=	Activity	uM	11.4	CHEMBL6029	Homo sapiens	Activity	uM	11.4
	13866258	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	COc1cccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)c1		CHEMBL3099998	=	Activity	uM	26.0	CHEMBL6029	Homo sapiens	Activity	uM	26.0
	13866259	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	Cc1cccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)c1		CHEMBL3099995	=	Activity	uM	24.1	CHEMBL6029	Homo sapiens	Activity	uM	24.1
	13866260	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099992	=	Activity	uM	0.7	CHEMBL6029	Homo sapiens	Activity	uM	0.7
	13866261	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1ccc(C(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099990	=	Activity	uM	1.6	CHEMBL6029	Homo sapiens	Activity	uM	1.6
	13866262	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3099989	=	Activity	uM	4.5	CHEMBL6029	Homo sapiens	Activity	uM	4.5
	13866263	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1ccc(I)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099987	=	Activity	uM	6.3	CHEMBL6029	Homo sapiens	Activity	uM	6.3
	13866264	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(I)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099986	=	Activity	uM	5.6	CHEMBL6029	Homo sapiens	Activity	uM	5.6
	13866265	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1ccccc1I)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099985	=	Activity	uM	18.5	CHEMBL6029	Homo sapiens	Activity	uM	18.5
	13866266	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(Br)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099983	=	Activity	uM	5.7	CHEMBL6029	Homo sapiens	Activity	uM	5.7
	13866267	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1ccccc1Br)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100024	=	Activity	uM	16.4	CHEMBL6029	Homo sapiens	Activity	uM	16.4
	13866268	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(Cl)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100022	=	Activity	uM	6.4	CHEMBL6029	Homo sapiens	Activity	uM	6.4
	13866269	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1ccccc1Cl)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100021	=	Activity	uM	18.5	CHEMBL6029	Homo sapiens	Activity	uM	18.5
	13866270	CHEMBL3101099	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as concentration required to obtain F-luciferase expression/R-luciferase expression ratio 3	B	O=C(Nc1cccc(F)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100019	=	Activity	uM	13.5	CHEMBL6029	Homo sapiens	Activity	uM	13.5
Active	13866293	CHEMBL3101102	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as eIF2alpha phosphorylation after 8 to 32 hrs by dual-luciferase reporter gene assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CCCC[C@@H]1Oc1ccc(C(F)(F)F)cc1		CHEMBL3099980		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866294	CHEMBL3101102	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as eIF2alpha phosphorylation after 8 to 32 hrs by dual-luciferase reporter gene assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](OCc2ccc(F)cc2)CC1		CHEMBL3099981		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866295	CHEMBL3101102	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as eIF2alpha phosphorylation after 8 to 32 hrs by dual-luciferase reporter gene assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2cccc(F)c2)CC1		CHEMBL3100013		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866296	CHEMBL3101102	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as eIF2alpha phosphorylation after 8 to 32 hrs by dual-luciferase reporter gene assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccccc2F)CC1		CHEMBL3100012		Activity			CHEMBL6029	Homo sapiens	Activity		
Not Active	13866317	CHEMBL3101107	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as eIF2alpha phosphorylation after 10 hrs by dual-luciferase reporter gene assay in presence of siRNA relative to control	B	O=C(Nc1ccc([N+](=O)[O-])cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100002		Activity			CHEMBL6029	Homo sapiens	Activity		
Not Active	13866318	CHEMBL3101107	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as eIF2alpha phosphorylation after 10 hrs by dual-luciferase reporter gene assay in presence of siRNA relative to control	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099992		Activity			CHEMBL6029	Homo sapiens	Activity		
Not Active	13866319	CHEMBL3101107	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as eIF2alpha phosphorylation after 10 hrs by dual-luciferase reporter gene assay in presence of siRNA relative to control	B	O=C(Nc1ccc(C(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099990		Activity			CHEMBL6029	Homo sapiens	Activity		
Not Active	13866320	CHEMBL3101107	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as eIF2alpha phosphorylation after 10 hrs by dual-luciferase reporter gene assay in presence of siRNA relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3099989		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866321	CHEMBL3101108	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1ccc([N+](=O)[O-])cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100002		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866322	CHEMBL3101108	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099992		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866323	CHEMBL3101108	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1ccc(C(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099990		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866324	CHEMBL3101108	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3099989		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866325	CHEMBL3101108	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1ccccc1C(F)(F)F)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099988		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866326	CHEMBL3101108	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1cccc(F)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100019		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866327	CHEMBL3101109	Activation of HRI in human CRL2813 cells assessed as increase in CHOP mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1ccc([N+](=O)[O-])cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100002		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866328	CHEMBL3101109	Activation of HRI in human CRL2813 cells assessed as increase in CHOP mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099992		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866329	CHEMBL3101109	Activation of HRI in human CRL2813 cells assessed as increase in CHOP mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1ccc(C(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099990		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866330	CHEMBL3101109	Activation of HRI in human CRL2813 cells assessed as increase in CHOP mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3099989		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866331	CHEMBL3101109	Activation of HRI in human CRL2813 cells assessed as increase in CHOP mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1ccccc1C(F)(F)F)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099988		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866332	CHEMBL3101109	Activation of HRI in human CRL2813 cells assessed as increase in CHOP mRNA expression at 7.5 to 15 uM after 6 hrs by RT-PCR analysis	B	O=C(Nc1cccc(F)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100019		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866333	CHEMBL3101110	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1ccc([N+](=O)[O-])cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100002		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866334	CHEMBL3101110	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099992		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866335	CHEMBL3101110	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1ccc(C(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099990		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866336	CHEMBL3101110	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3099989		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866337	CHEMBL3101110	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1ccccc1C(F)(F)F)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099988		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866338	CHEMBL3101110	Activation of HRI in human CRL2813 cells assessed as reduction in cyclin D1 protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1cccc(F)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100019		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866339	CHEMBL3101111	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1ccc([N+](=O)[O-])cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100002		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866340	CHEMBL3101111	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099992		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866341	CHEMBL3101111	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1ccc(C(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099990		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866342	CHEMBL3101111	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3099989		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866343	CHEMBL3101111	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1ccccc1C(F)(F)F)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099988		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866344	CHEMBL3101111	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 10 uM after 6 hrs by Western blotting analysis	B	O=C(Nc1cccc(F)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100019		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866345	CHEMBL3101112	Activation of HRI in human CRL2813 cells assessed as eIF2alpha phosphorylation after 6 hrs by Western blotting analysis	B	O=C(Nc1ccc([N+](=O)[O-])cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100002		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866346	CHEMBL3101112	Activation of HRI in human CRL2813 cells assessed as eIF2alpha phosphorylation after 6 hrs by Western blotting analysis	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099992		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866347	CHEMBL3101112	Activation of HRI in human CRL2813 cells assessed as eIF2alpha phosphorylation after 6 hrs by Western blotting analysis	B	O=C(Nc1ccc(C(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099990		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866348	CHEMBL3101112	Activation of HRI in human CRL2813 cells assessed as eIF2alpha phosphorylation after 6 hrs by Western blotting analysis	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3099989		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866349	CHEMBL3101112	Activation of HRI in human CRL2813 cells assessed as eIF2alpha phosphorylation after 6 hrs by Western blotting analysis	B	O=C(Nc1ccccc1C(F)(F)F)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099988		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	13866350	CHEMBL3101112	Activation of HRI in human CRL2813 cells assessed as eIF2alpha phosphorylation after 6 hrs by Western blotting analysis	B	O=C(Nc1cccc(F)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100019		Activity			CHEMBL6029	Homo sapiens	Activity		
	13867019	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CCC[C@H](Oc2ccc(C(F)(F)F)cc2)C1		CHEMBL3099979	=	Ratio		4.52	CHEMBL6029	Homo sapiens	Ratio		4.52
	13867020	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CCCC[C@@H]1Oc1ccc(C(F)(F)F)cc1		CHEMBL3099980	=	Ratio		5.89	CHEMBL6029	Homo sapiens	Ratio		5.89
	13867021	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](OCc2ccc(F)cc2)CC1		CHEMBL3099981	=	Ratio		9.58	CHEMBL6029	Homo sapiens	Ratio		9.58
	13867022	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](O)CC1		CHEMBL3099982	=	Ratio		0.89	CHEMBL6029	Homo sapiens	Ratio		0.89
	13867023	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)NC1CCCCC1		CHEMBL1610486	=	Ratio		1.87	CHEMBL6029	Homo sapiens	Ratio		1.87
	13867024	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2cccc(C(F)(F)F)c2)CC1		CHEMBL3100017	=	Ratio		26.0	CHEMBL6029	Homo sapiens	Ratio		26.0
	13867025	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccccc2C(F)(F)F)CC1		CHEMBL3100016	=	Ratio		15.74	CHEMBL6029	Homo sapiens	Ratio		15.74
	13867026	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL3098149	=	Ratio		25.12	CHEMBL6029	Homo sapiens	Ratio		25.12
	13867027	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(OC(F)(F)F)cc2)CC1		CHEMBL3100015	=	Ratio		14.42	CHEMBL6029	Homo sapiens	Ratio		14.42
	13867028	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(Cl)cc2)CC1		CHEMBL3100014	=	Ratio		6.73	CHEMBL6029	Homo sapiens	Ratio		6.73
	13867029	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2cccc(F)c2)CC1		CHEMBL3100013	=	Ratio		7.23	CHEMBL6029	Homo sapiens	Ratio		7.23
	13867030	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccccc2F)CC1		CHEMBL3100012	=	Ratio		7.98	CHEMBL6029	Homo sapiens	Ratio		7.98
	13867031	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(C(=O)O)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100011	=	Ratio		3.49	CHEMBL6029	Homo sapiens	Ratio		3.49
	13867032	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(=O)O)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100010	=	Ratio		0.88	CHEMBL6029	Homo sapiens	Ratio		0.88
	13867033	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccccc1C(=O)O)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3100009	=	Ratio		1.2	CHEMBL6029	Homo sapiens	Ratio		1.2
	13867034	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	COC(=O)c1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)cc1		CHEMBL3100008	=	Ratio		3.97	CHEMBL6029	Homo sapiens	Ratio		3.97
	13867035	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	COC(=O)c1cccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)c1		CHEMBL3100007	=	Ratio		6.83	CHEMBL6029	Homo sapiens	Ratio		6.83
	13867036	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	COC(=O)c1ccccc1NC(=O)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3100006	=	Ratio		3.79	CHEMBL6029	Homo sapiens	Ratio		3.79
	13867037	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	CSc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)cc1		CHEMBL3100005	=	Ratio		1.07	CHEMBL6029	Homo sapiens	Ratio		1.07
	13867038	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	CSc1cccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)c1		CHEMBL3100004	=	Ratio		6.67	CHEMBL6029	Homo sapiens	Ratio		6.67
	13867039	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	CSc1ccccc1NC(=O)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100003	=	Ratio		0.92	CHEMBL6029	Homo sapiens	Ratio		0.92
	13867040	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccc([N+](=O)[O-])cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100002	=	Ratio		9.0	CHEMBL6029	Homo sapiens	Ratio		9.0
	13867041	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc([N+](=O)[O-])c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100001	=	Ratio		7.47	CHEMBL6029	Homo sapiens	Ratio		7.47
	13867042	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccccc1[N+](=O)[O-])N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100000	=	Ratio		2.23	CHEMBL6029	Homo sapiens	Ratio		2.23
	13867043	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	COc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)cc1		CHEMBL3099999	=	Ratio		0.83	CHEMBL6029	Homo sapiens	Ratio		0.83
	13867044	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	COc1cccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)c1		CHEMBL3099998	=	Ratio		3.81	CHEMBL6029	Homo sapiens	Ratio		3.81
	13867045	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	COc1ccccc1NC(=O)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099997	=	Ratio		1.51	CHEMBL6029	Homo sapiens	Ratio		1.51
	13867046	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)cc1		CHEMBL3099996	=	Ratio		1.05	CHEMBL6029	Homo sapiens	Ratio		1.05
	13867047	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	Cc1cccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)c1		CHEMBL3099995	=	Ratio		4.73	CHEMBL6029	Homo sapiens	Ratio		4.73
	13867048	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	Cc1ccccc1NC(=O)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099994	=	Ratio		0.98	CHEMBL6029	Homo sapiens	Ratio		0.98
	13867049	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccccc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099993	=	Ratio		1.65	CHEMBL6029	Homo sapiens	Ratio		1.65
	13867050	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099992	=	Ratio		15.32	CHEMBL6029	Homo sapiens	Ratio		15.32
	13867051	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccccc1OC(F)(F)F)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099991	=	Ratio		1.41	CHEMBL6029	Homo sapiens	Ratio		1.41
	13867052	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(C(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099990	=	Ratio		13.99	CHEMBL6029	Homo sapiens	Ratio		13.99
	13867053	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@@H](Oc2ccc(F)cc2)CC1		CHEMBL3099989	=	Ratio		11.84	CHEMBL6029	Homo sapiens	Ratio		11.84
	13867054	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccccc1C(F)(F)F)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099988	=	Ratio		1.56	CHEMBL6029	Homo sapiens	Ratio		1.56
	13867055	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(I)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099987	=	Ratio		3.77	CHEMBL6029	Homo sapiens	Ratio		3.77
	13867056	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(I)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099986	=	Ratio		7.63	CHEMBL6029	Homo sapiens	Ratio		7.63
	13867057	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccccc1I)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099985	=	Ratio		3.25	CHEMBL6029	Homo sapiens	Ratio		3.25
	13867058	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(Br)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099984	=	Ratio		1.29	CHEMBL6029	Homo sapiens	Ratio		1.29
	13867059	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(Br)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3099983	=	Ratio		9.52	CHEMBL6029	Homo sapiens	Ratio		9.52
	13867060	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccccc1Br)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100024	=	Ratio		5.23	CHEMBL6029	Homo sapiens	Ratio		5.23
	13867061	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(Cl)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100023	=	Ratio		1.65	CHEMBL6029	Homo sapiens	Ratio		1.65
	13867062	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(Cl)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100022	=	Ratio		8.76	CHEMBL6029	Homo sapiens	Ratio		8.76
	13867063	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccccc1Cl)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100021	=	Ratio		5.37	CHEMBL6029	Homo sapiens	Ratio		5.37
	13867064	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccc(F)cc1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100020	=	Ratio		0.98	CHEMBL6029	Homo sapiens	Ratio		0.98
	13867065	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1cccc(F)c1)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100019	=	Ratio		6.54	CHEMBL6029	Homo sapiens	Ratio		6.54
	13867066	CHEMBL3101114	Activation of HRI in human CRL-2813-pBISA-DL(ATF-4) reporter cells assessed as reduction of ternary complex at 30 uM by dual-luciferase reporter gene assay relative to control	B	O=C(Nc1ccccc1F)N[C@H]1CC[C@H](Oc2ccc(F)cc2)CC1		CHEMBL3100018	=	Ratio		2.1	CHEMBL6029	Homo sapiens	Ratio		2.1
	15207538	CHEMBL3412170	Inhibition of HRI (unknown origin)	B	CNc1ncc2cc(-c3c(C)ccc(C(=O)Nc4ccc(OC)c(C(F)(F)F)c4)c3N)ccc2n1		CHEMBL3407847	>	IC50	nM	10000.0	CHEMBL6029	Homo sapiens	IC50	uM	10.0
	15207539	CHEMBL3412170	Inhibition of HRI (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(-c5ccccc5)n(C)n(-c5ccccc5)c4=O)nc3)c2cc1OC		CHEMBL3407848	>	IC50	nM	10000.0	CHEMBL6029	Homo sapiens	IC50	uM	10.0
Inactive	17898532	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898533	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898534	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898535	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898536	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898537	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898538	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898539	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898540	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898541	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898542	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898543	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898544	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898545	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898546	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898547	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898548	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	3342.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	3342.0
Inactive	17898549	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898550	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898551	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898552	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	170.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	170.0
Inactive	17898553	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898554	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898555	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898556	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898557	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	1080.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	1080.0
Inactive	17898558	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898559	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898560	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898561	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898562	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898563	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898564	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898565	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	3292.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	3292.0
Inactive	17898566	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898567	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898568	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898569	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898570	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898571	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898572	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898573	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898574	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898575	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898576	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898577	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898578	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898579	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898580	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898581	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898582	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17898583	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	=	Kd	nM	1821.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	1821.0
Inactive	17898584	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898585	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898586	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898587	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	666.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	666.0
Inactive	17898588	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898589	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898590	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898591	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898592	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898593	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898594	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898595	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898596	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898597	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898598	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898599	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898600	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898601	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898602	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898603	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	4836.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	4836.0
Inactive	17898604	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17898605	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	3724.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	3724.0
Inactive	17898606	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898607	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898608	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898609	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898610	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898611	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898612	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898613	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898614	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898615	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2047.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	2047.0
Inactive	17898616	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898617	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898618	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898619	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898620	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898621	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898622	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898623	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898624	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898625	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898626	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898627	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898628	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898629	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898630	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898631	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898632	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898633	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898634	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898635	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898636	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898637	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898638	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898639	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898640	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898641	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898642	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898643	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898644	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898645	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898646	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898647	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898648	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898649	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898650	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898651	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898652	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898653	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898654	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898655	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898656	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898657	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898658	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898659	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898660	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898661	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898662	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898663	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898664	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17898665	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	58.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	58.0
Inactive	17898666	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898667	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898668	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898669	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898670	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898671	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898672	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898673	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898674	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898675	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898676	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898677	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898678	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898679	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898680	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898681	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898682	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898683	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898684	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898685	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898686	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898687	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898688	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898689	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898690	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898691	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898692	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898693	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898694	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898695	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898696	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898697	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898698	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898699	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898700	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898701	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898702	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17898703	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	4326.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	4326.0
Inactive	17898704	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898705	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898706	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898707	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898708	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898709	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898710	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	1661.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	1661.0
Inactive	17898711	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898712	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898713	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898714	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898715	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898716	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898717	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	3803.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	3803.0
Inactive	17898718	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898719	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898720	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898721	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898722	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898723	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898724	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898725	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898726	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898727	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898728	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898729	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898730	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898731	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	949.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	949.0
Inactive	17898732	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898733	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898734	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	3572.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	3572.0
Inactive	17898735	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898736	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898737	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898738	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898739	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898740	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898741	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898742	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898743	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898744	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898745	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898746	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898747	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898748	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898749	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898750	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898751	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898752	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898753	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898754	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898755	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898756	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898757	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898758	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898759	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898760	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898761	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898762	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898763	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898764	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898765	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	17898766	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	335.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	335.0
Inactive	17898767	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898768	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898769	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898770	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17898771	CHEMBL3991697	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL6029	Homo sapiens	Kd apparent	nM	30000.0
Active	18059181	CHEMBL4012852	Activation of HRI in human CRL2813 cells assessed as increase in eIF2alpha phosphorylation at 5 uM after 2 hrs by Western blot analysis	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL3098149		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059182	CHEMBL4012852	Activation of HRI in human CRL2813 cells assessed as increase in eIF2alpha phosphorylation at 5 uM after 2 hrs by Western blot analysis	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL4095536		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059183	CHEMBL4012852	Activation of HRI in human CRL2813 cells assessed as increase in eIF2alpha phosphorylation at 5 uM after 2 hrs by Western blot analysis	B	N#Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc1		CHEMBL4087831		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059184	CHEMBL4012852	Activation of HRI in human CRL2813 cells assessed as increase in eIF2alpha phosphorylation at 5 uM after 2 hrs by Western blot analysis	B	N#Cc1cc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc(C(F)(F)F)c1		CHEMBL4086884		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059185	CHEMBL4012852	Activation of HRI in human CRL2813 cells assessed as increase in eIF2alpha phosphorylation at 5 uM after 2 hrs by Western blot analysis	B	N#Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc1C#N		CHEMBL4103285		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059186	CHEMBL4012852	Activation of HRI in human CRL2813 cells assessed as increase in eIF2alpha phosphorylation at 5 uM after 2 hrs by Western blot analysis	B	O=C(Nc1cccc(OC(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL4073219		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059187	CHEMBL4012853	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 5 uM after 8 hrs by Western blot analysis	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL3098149		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059188	CHEMBL4012853	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 5 uM after 8 hrs by Western blot analysis	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL4095536		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059189	CHEMBL4012853	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 5 uM after 8 hrs by Western blot analysis	B	N#Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc1		CHEMBL4087831		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059190	CHEMBL4012853	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 5 uM after 8 hrs by Western blot analysis	B	N#Cc1cc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc(C(F)(F)F)c1		CHEMBL4086884		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059191	CHEMBL4012853	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 5 uM after 8 hrs by Western blot analysis	B	N#Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc1C#N		CHEMBL4103285		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059192	CHEMBL4012853	Activation of HRI in human CRL2813 cells assessed as increase in CHOP protein expression at 5 uM after 8 hrs by Western blot analysis	B	O=C(Nc1cccc(OC(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL4073219		Activity			CHEMBL6029	Homo sapiens	Activity		
	18059193	CHEMBL4012854	Activation of HRI in human CRL2813 cells assessed as induction of CHOP mRNA level at 5 uM by real-time PCR relative to 18S RNA	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL3098149	=	FC		4.72	CHEMBL6029	Homo sapiens	FC		4.72
	18059194	CHEMBL4012854	Activation of HRI in human CRL2813 cells assessed as induction of CHOP mRNA level at 5 uM by real-time PCR relative to 18S RNA	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL4095536	=	FC		14.47	CHEMBL6029	Homo sapiens	FC		14.47
	18059195	CHEMBL4012854	Activation of HRI in human CRL2813 cells assessed as induction of CHOP mRNA level at 5 uM by real-time PCR relative to 18S RNA	B	N#Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc1		CHEMBL4087831	=	FC		12.78	CHEMBL6029	Homo sapiens	FC		12.78
	18059196	CHEMBL4012854	Activation of HRI in human CRL2813 cells assessed as induction of CHOP mRNA level at 5 uM by real-time PCR relative to 18S RNA	B	N#Cc1cc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc(C(F)(F)F)c1		CHEMBL4086884	=	FC		9.87	CHEMBL6029	Homo sapiens	FC		9.87
	18059197	CHEMBL4012854	Activation of HRI in human CRL2813 cells assessed as induction of CHOP mRNA level at 5 uM by real-time PCR relative to 18S RNA	B	N#Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc1C#N		CHEMBL4103285	=	FC		6.21	CHEMBL6029	Homo sapiens	FC		6.21
	18059198	CHEMBL4012854	Activation of HRI in human CRL2813 cells assessed as induction of CHOP mRNA level at 5 uM by real-time PCR relative to 18S RNA	B	O=C(Nc1cccc(OC(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL4073219	=	FC		11.86	CHEMBL6029	Homo sapiens	FC		11.86
Active	18059199	CHEMBL4012855	Activation of HRI in human CRL2813cells assessed as decrease in cyclin D1 protein expression at 5 uM after 8 hrs by Western blot analysis	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL3098149		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059200	CHEMBL4012855	Activation of HRI in human CRL2813cells assessed as decrease in cyclin D1 protein expression at 5 uM after 8 hrs by Western blot analysis	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL4095536		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059201	CHEMBL4012855	Activation of HRI in human CRL2813cells assessed as decrease in cyclin D1 protein expression at 5 uM after 8 hrs by Western blot analysis	B	N#Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc1		CHEMBL4087831		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059202	CHEMBL4012855	Activation of HRI in human CRL2813cells assessed as decrease in cyclin D1 protein expression at 5 uM after 8 hrs by Western blot analysis	B	N#Cc1cc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc(C(F)(F)F)c1		CHEMBL4086884		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059203	CHEMBL4012855	Activation of HRI in human CRL2813cells assessed as decrease in cyclin D1 protein expression at 5 uM after 8 hrs by Western blot analysis	B	N#Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C(F)(F)F)cc3)CC2)cc1C#N		CHEMBL4103285		Activity			CHEMBL6029	Homo sapiens	Activity		
Active	18059204	CHEMBL4012855	Activation of HRI in human CRL2813cells assessed as decrease in cyclin D1 protein expression at 5 uM after 8 hrs by Western blot analysis	B	O=C(Nc1cccc(OC(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1		CHEMBL4073219		Activity			CHEMBL6029	Homo sapiens	Activity		
	18114382	CHEMBL4025112	Inhibition of wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	84.0	CHEMBL6029	Homo sapiens	Activity	%	84.0
	18203636	CHEMBL4043923	Inhibition of wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL6029	Homo sapiens	Activity	%	100.0
	18253648	CHEMBL4055108	Inhibition of wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	94.0	CHEMBL6029	Homo sapiens	Activity	%	94.0
	18253649	CHEMBL4055108	Inhibition of wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL6029	Homo sapiens	Activity	%	96.0
	18440178	CHEMBL4157002	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	92.0	CHEMBL6029	Homo sapiens	Activity	%	92.0
	18484618	CHEMBL4185781	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	93.0	CHEMBL6029	Homo sapiens	Activity	%	93.0
	18485003	CHEMBL4185781	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL6029	Homo sapiens	Activity	%	100.0
	18507760	CHEMBL4191002	Inhibition of recombinant human HRI (140 to end residues) at 1 uM using RSRSRSRSRSRSRSR as substrate after 120 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	Outside typical range	CHEMBL4207014	=	Inhibition	%	-11.0	CHEMBL6029	Homo sapiens	INH	%	-11.0
	18655554	CHEMBL4230681	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL6029	Homo sapiens	Activity	%	100.0
	18737820	CHEMBL4261419	Inhibition of recombinant human HRI (140 to end residues) using RSRSRSRSRSRSR as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	26.0	CHEMBL6029	Homo sapiens	IC50	nM	26.0
	18751633	CHEMBL4264270	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	97.0	CHEMBL6029	Homo sapiens	Activity	%	97.0
	18857939	CHEMBL4307785	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	82.0	CHEMBL6029	Homo sapiens	Activity	%	82.0
	18892627	CHEMBL4314674	Inhibition of recombinant human HRI (140 to end residues) assessed as residual activity at 10 uM using RSRSRSRSRSRSRSR as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	102.5	CHEMBL6029	Homo sapiens	Activity	%	102.5
	18958856	CHEMBL4333375	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL6029	Homo sapiens	Activity	%	100.0
	18964353	CHEMBL4335114	Inhibition of human HRI (140 to end residues) assessed as residual activity at 1 uM using RSRSRSRSRSRSRSR as substrate after 120 mins by [gamma-33ATP] radiometric assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	96.0	CHEMBL6029	Homo sapiens	Activity	%	96.0
	18964354	CHEMBL4335114	Inhibition of human HRI (140 to end residues) assessed as residual activity at 1 uM using RSRSRSRSRSRSRSR as substrate after 120 mins by [gamma-33ATP] radiometric assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	101.0	CHEMBL6029	Homo sapiens	Activity	%	101.0
	18971931	CHEMBL4336941	Inhibition of human HRI (140 to end residues) assessed as residual activity at 10 uM using RSRSRSRSRSRSR as substrate after 120 mins by [gamma-33ATP] radiometric assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	91.0	CHEMBL6029	Homo sapiens	Activity	%	91.0
Not Active	19039750	CHEMBL4351892	Inhibition of recombinant human HRI (140 to end residues) at 10 uM using RSRSRSRSRSRSRSR as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL6029	Homo sapiens	INH		
	19059558	CHEMBL4357859	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL6029	Homo sapiens	Activity	%	100.0
	19090129	CHEMBL4365703	Inhibition of wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL6029	Homo sapiens	Activity	%	100.0
	19092184	CHEMBL4366658	Inhibition of human EIF2AK1 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	3.42	CHEMBL6029	Homo sapiens	INH	%	3.42
	19144872	CHEMBL4377888	Inhibition of recombinant human HRI (140 to end residues) at 1 uM using RSRSRSRSRSRSRSR as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	30.0	CHEMBL6029	Homo sapiens	INH	%	30.0
	19147882	CHEMBL4379356	Inhibition of human recombinant HRI (140 to end residues) using RSRSRSRSRSRSR as substrate after 120 mins by [gamma-33ATP] radiometric assay	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL6029	Homo sapiens	IC50	uM	10.0
	19159386	CHEMBL4382490	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	72.0	CHEMBL6029	Homo sapiens	Activity	%	72.0
	19191621	CHEMBL4389209	Inhibition of wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL6029	Homo sapiens	INH	%	100.0
	19191872	CHEMBL4389686	Inhibition of wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL6029	Homo sapiens	INH	%	100.0
	19199910	CHEMBL4391312	Binding affinity to wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL6029	Homo sapiens	Activity	%	100.0
	19266675	CHEMBL4405625	Inhibition of wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL6029	Homo sapiens	INH	%	50.0
	22815896	CHEMBL4714742	Inhibition of wild-type human partial length EIF2AK1 (Q147 to E603 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	CNC(=O)CN(Cc1ccccc1OC(F)F)C(=O)c1c[nH]c(C(=O)N2CCCC2)n1		CHEMBL4779479	>	Inhibition	%	65.0	CHEMBL6029	Homo sapiens	INH	%	65.0
	23122544	CHEMBL4804895	Inhibition of human EIF2AK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	84.0	CHEMBL6029	Homo sapiens	Activity	%	84.0
	23123239	CHEMBL4805483	Inhibition of human EIF2AK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	73.0	CHEMBL6029	Homo sapiens	Activity	%	73.0
	23123652	CHEMBL4805896	Inhibition of DNA-tagged human EIF2AK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	64.0	CHEMBL6029	Homo sapiens	Activity	%	64.0
	23124568	CHEMBL4806500	Inhibition of human EIF2AK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	93.0	CHEMBL6029	Homo sapiens	Activity	%	93.0
	23124569	CHEMBL4806500	Inhibition of human EIF2AK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	78.0	CHEMBL6029	Homo sapiens	Activity	%	78.0
	23128170	CHEMBL4807865	Inhibition of HRI (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL6029	Homo sapiens	Activity	%	75.0
	23128171	CHEMBL4807865	Inhibition of HRI (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL6029	Homo sapiens	Activity	%	75.0
	23128172	CHEMBL4807865	Inhibition of HRI (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL6029	Homo sapiens	Activity	%	75.0
Not Active	23317379	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23317847	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23318517	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23318997	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23319634	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23320109	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23320787	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23321255	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	93.0	CHEMBL6029	Homo sapiens	% Control	%	93.0
Not Active	23321885	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	84.0	CHEMBL6029	Homo sapiens	% Control	%	84.0
Not Active	23322353	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	86.0	CHEMBL6029	Homo sapiens	% Control	%	86.0
Not Active	23323042	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	98.0	CHEMBL6029	Homo sapiens	% Control	%	98.0
Not Active	23323510	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23324364	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23324999	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	78.0	CHEMBL6029	Homo sapiens	% Control	%	78.0
Not Active	23325467	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23326114	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	83.0	CHEMBL6029	Homo sapiens	% Control	%	83.0
Not Active	23326582	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	95.0	CHEMBL6029	Homo sapiens	% Control	%	95.0
Not Active	23327282	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	86.0	CHEMBL6029	Homo sapiens	% Control	%	86.0
Not Active	23327750	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	94.0	CHEMBL6029	Homo sapiens	% Control	%	94.0
Not Active	23328337	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23328805	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23329371	CHEMBL4881078	HRI(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	104.0	CHEMBL6029	Homo sapiens	% residual kinase activity	%	104.0
Not Active	23329751	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23330219	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	85.0	CHEMBL6029	Homo sapiens	% Control	%	85.0
Not Active	23330975	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	90.0	CHEMBL6029	Homo sapiens	% Control	%	90.0
Not Active	23331443	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23332030	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23332496	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23333214	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23333853	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23334321	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23335300	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	77.0	CHEMBL6029	Homo sapiens	% Control	%	77.0
Not Active	23335768	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23336395	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	91.0	CHEMBL6029	Homo sapiens	% Control	%	91.0
Not Active	23336863	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23337944	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	96.0	CHEMBL6029	Homo sapiens	% Control	%	96.0
Not Active	23338412	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	88.0	CHEMBL6029	Homo sapiens	% Control	%	88.0
Not Active	23339024	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23339492	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	80.0	CHEMBL6029	Homo sapiens	% Control	%	80.0
Not Active	23340129	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	73.0	CHEMBL6029	Homo sapiens	% Control	%	73.0
Not Active	23340597	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23341254	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23341722	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	83.0	CHEMBL6029	Homo sapiens	% Control	%	83.0
Not Active	23342338	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	93.0	CHEMBL6029	Homo sapiens	% Control	%	93.0
Not Active	23342806	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	88.0	CHEMBL6029	Homo sapiens	% Control	%	88.0
Not Active	23343436	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	91.0	CHEMBL6029	Homo sapiens	% Control	%	91.0
Not Active	23343904	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	90.0	CHEMBL6029	Homo sapiens	% Control	%	90.0
Not Active	23344542	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	84.0	CHEMBL6029	Homo sapiens	% Control	%	84.0
Not Active	23345115	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	96.0	CHEMBL6029	Homo sapiens	% Control	%	96.0
Not Active	23345583	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23346160	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23346629	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	83.4	CHEMBL6029	Homo sapiens	% Control	%	83.4
Not Active	23347237	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	92.8	CHEMBL6029	Homo sapiens	% Control	%	92.8
Not Active	23347720	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23348299	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	68.0	CHEMBL6029	Homo sapiens	% Control	%	68.0
Not Active	23348767	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	83.0	CHEMBL6029	Homo sapiens	% Control	%	83.0
Not Active	23349354	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23349972	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23350440	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	93.0	CHEMBL6029	Homo sapiens	% Control	%	93.0
Not Active	23351045	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	98.0	CHEMBL6029	Homo sapiens	% Control	%	98.0
Not Active	23351513	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	90.0	CHEMBL6029	Homo sapiens	% Control	%	90.0
Not Active	23352537	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23353005	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	60.0	CHEMBL6029	Homo sapiens	% Control	%	60.0
Not Active	23353887	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	98.0	CHEMBL6029	Homo sapiens	% Control	%	98.0
Not Active	23354355	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	77.0	CHEMBL6029	Homo sapiens	% Control	%	77.0
Not Active	23355087	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23355555	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23356191	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23356659	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23357268	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	84.0	CHEMBL6029	Homo sapiens	% Control	%	84.0
Not Active	23357915	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23358383	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23358969	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	88.0	CHEMBL6029	Homo sapiens	% Control	%	88.0
Not Active	23359567	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23360035	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	95.0	CHEMBL6029	Homo sapiens	% Control	%	95.0
Not Active	23360620	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23361088	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	94.0	CHEMBL6029	Homo sapiens	% Control	%	94.0
Not Active	23361661	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	98.0	CHEMBL6029	Homo sapiens	% Control	%	98.0
Not Active	23362197	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23362665	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23364307	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23364775	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	84.0	CHEMBL6029	Homo sapiens	% Control	%	84.0
Not Active	23365514	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	98.0	CHEMBL6029	Homo sapiens	% Control	%	98.0
Not Active	23366057	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23366647	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23367115	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	95.0	CHEMBL6029	Homo sapiens	% Control	%	95.0
Not Active	23367596	CHEMBL4883949	HRI ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	106.0	CHEMBL6029	Homo sapiens	% Residual activity with Skepinone-L	%	106.0
Not Active	23367993	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23368461	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23369060	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23369528	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	54.0	CHEMBL6029	Homo sapiens	% Control	%	54.0
Not Active	23370093	CHEMBL4884337	HRI(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	100.0	CHEMBL6029	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23370496	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23370964	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23371773	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	91.0	CHEMBL6029	Homo sapiens	% Control	%	91.0
Not Active	23372241	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	81.0	CHEMBL6029	Homo sapiens	% Control	%	81.0
	23372726	CHEMBL4884691	HRI(EIK1CGQ1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL6029	Homo sapiens	pIC50		6.0
	23373135	CHEMBL4884982	HRI(EIK1CGQ1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL6029	Homo sapiens	pIC50		6.0
	23373496	CHEMBL4885273	HRI(EIK1CGQ1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL6029	Homo sapiens	pIC50		6.0
Not Active	23375668	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23376136	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23376713	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	97.0	CHEMBL6029	Homo sapiens	% Control	%	97.0
Not Active	23377182	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	79.0	CHEMBL6029	Homo sapiens	% Control	%	79.0
Not Active	23378041	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	80.0	CHEMBL6029	Homo sapiens	% Control	%	80.0
Not Active	23378509	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	96.0	CHEMBL6029	Homo sapiens	% Control	%	96.0
Not Active	23379676	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	86.0	CHEMBL6029	Homo sapiens	% Control	%	86.0
Not Active	23380144	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	83.0	CHEMBL6029	Homo sapiens	% Control	%	83.0
Not Active	23380838	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	94.0	CHEMBL6029	Homo sapiens	% Control	%	94.0
Not Active	23381486	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	93.0	CHEMBL6029	Homo sapiens	% Control	%	93.0
Not Active	23381954	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23382578	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	85.0	CHEMBL6029	Homo sapiens	% Control	%	85.0
Not Active	23383046	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	87.0	CHEMBL6029	Homo sapiens	% Control	%	87.0
Not Active	23384301	CHEMBL4887896	HRI(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-6.26	CHEMBL6029	Homo sapiens	% inhibition	%	-6.26
Not Active	23384961	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
Not Active	23385428	CHEMBL4879685	KinomeScan assay: inhibition of EIF2AK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL6029	Homo sapiens	% Control	%	100.0
